(CS-082) Advanced Multi-Tissue Platform (MTP) Particulate Facilitates Complex Wound Healing in Patients With Limited Availability for Clinic Followup
Friday, April 28, 2023
7:15 PM - 8:30 PM East Coast USA Time
Matthew Hardy, MD, CWSP
Introduction: Chronic and complex wounds present a costly challenge. Close clinic follow-up is often required in these demanding cases, however adherence to frequent scheduling is difficult for select patient populations, including those working or with limited access to transportation. Often, reducing frequency of clinic follow-up compromises wound healing. However, here we have identified an advanced, affordable, non-human Multi-Tissue Platform (MTP)* that provides autonomy by enabling patients or caregiver application of advanced treatment independently at home. This unique, micronized MTP product is derived from porcine spleen and lung, and comprised of multiple growth factors, collagen, hyaluronic acid, and glycosaminoglycans. Providing a simple, cost-effective, reliable regimen that can be applied independently by patient or caregiver stimulates wound advancement in difficult-to-treat patient populations with limited availability for clinic follow-up.
Methods: Two patients with complex surgical wounds, and one patient with chronic recurrent venous ulcer in the shadow of a large, bulky surgical flap were included. All wounds were stalled or deteriorating, and the patients were unavailable for the recommended follow-up of once to twice per week. All patients received the micronized MTP product, with instructions to apply the product directly to the wound, cover with absorbent secondary dressing, and secure in place. Wound care was applied every other day by patient or caregiver, with follow-up in clinic reduced to once every 3+ weeks.
Results: All wounds improved significantly with independent application of the MTP particulate by patient or caregiver. Patients were satisfied with the autonomy provided to them, without compromising wound progress.
Discussion: This innovative MTP product provides an advanced, cost-effective dressing that promotes wound healing in stalled or deteriorating complex wounds. Furthermore, the user-friendly application enables advanced dressing application independently by the patient or caregiver, promoting wound healing in the difficult-to-heal population of patients who are unable to present for frequent clinic follow-up.